Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2019Biology of Blood and Marrow TransplantationOpen Access

Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMartin CarréRPRaphaël PorcherJFJürgen Finke

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Carré et al. (2019) studied this question.

synapsesocial.com/papers/69dcbd110de68e8319e533dfhttps://doi.org/10.1016/j.bbmt.2019.10.015
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multi‐centre validation of the prognostic value of the haematopoietic cell transplantation‐ specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation2015 · 55 citations
  2. 2Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome2010 · 481 citations
  3. 3Decitabine improves patient outcomes in myelodysplastic syndromes2006 · 1,534 citations
  4. 4Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT2005 · 2,979 citations
  5. 5Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine2012 · 94 citations